Cargando…
COVID-19-Associated Pulmonary Mucormycosis
COVID-19-associated mucormycosis (CAM) emerged as an epidemic in certain parts of the world amidst the global COVID-19 pandemic. While rhino–orbital mucormycosis was well reported during the pandemic, in the absence of routine diagnostic facilities including lower airway sampling, pulmonary mucormyc...
Autores principales: | Krishna, Vidya, Bansal, Nitin, Morjaria, Jaymin, Kaul, Sundeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315775/ https://www.ncbi.nlm.nih.gov/pubmed/35887466 http://dx.doi.org/10.3390/jof8070711 |
Ejemplares similares
-
Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infection
por: Krishna, Vidya, et al.
Publicado: (2021) -
Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic
por: Mehta, Ravindra M, et al.
Publicado: (2022) -
Covid-associated pulmonary mucormycosis
por: Kumar, Arvind, et al.
Publicado: (2022) -
Recommendation for optimal management of severe refractory asthma
por: Morjaria, Jaymin B, et al.
Publicado: (2010) -
COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis
por: Huang, Shiang-Fen, et al.
Publicado: (2023)